|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9122
|
|
pubmed:dateCreated |
1998-7-28
|
|
pubmed:abstractText |
Tamoxifen is a candidate chemopreventive agent in breast cancer, although the drug may be associated with the development of endometrial cancer. Therefore we did a trial in hysterectomised women of tamoxifen as a chemopreventive.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
11
|
|
pubmed:volume |
352
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9672273-Adult,
pubmed-meshheading:9672273-Aged,
pubmed-meshheading:9672273-Anticarcinogenic Agents,
pubmed-meshheading:9672273-Breast Neoplasms,
pubmed-meshheading:9672273-Double-Blind Method,
pubmed-meshheading:9672273-Drug Therapy, Combination,
pubmed-meshheading:9672273-Estrogen Replacement Therapy,
pubmed-meshheading:9672273-Female,
pubmed-meshheading:9672273-Follow-Up Studies,
pubmed-meshheading:9672273-Humans,
pubmed-meshheading:9672273-Hypertriglyceridemia,
pubmed-meshheading:9672273-Hysterectomy,
pubmed-meshheading:9672273-Incidence,
pubmed-meshheading:9672273-Italy,
pubmed-meshheading:9672273-Middle Aged,
pubmed-meshheading:9672273-Patient Dropouts,
pubmed-meshheading:9672273-Tamoxifen,
pubmed-meshheading:9672273-Vascular Diseases
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
|
|
pubmed:affiliation |
European Institute of Oncology, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
